Cipher Pharmaceuticals Inc. (CPH):企業の財務及び戦略的SWOT分析

◆英語タイトル:Cipher Pharmaceuticals Inc. (CPH) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム



Cipher Pharmaceuticals Inc. (Cipher) is a pharmaceutical company that develops formulations. The company develops improved formulations of existing drugs. It offers clinical and regulatory affairs, supply chain management, product licensing, and marketing and sales. Cipher provides cholesterol medication, fenofibrate, and formulation of isotretinoin for the treatment of severe acne, hyperlipidemia a cholesterol disorder, chronic pain and moderate to moderately severe pain. The company’s products include Lipofen, Conzip Durelae, and Absorica Epuris. It develops novel formulations for therapeutic areas of gastrointestinal, cardiovascular, dermatology and pain management. Cipher is headquartered in Mississauga, Ontario, Canada.

Cipher Pharmaceuticals Inc. Key Recent Developments

Nov 04, 2015: Cipher Reports Third Quarter Results
Aug 14, 2015: Cipher Reports Financial and Operational Results for Q2 2015
Jun 02, 2015: Cipher Pharmaceuticals Strengthens Leadership Team with Key Executive Appointments and Announces Launch of Vaniqa in Canada
May 13, 2015: Cipher Reports Financial and Operational Results for Q1 2015
Feb 25, 2015: Cipher Reports Financial Results for Fiscal 2014

This comprehensive SWOT profile of Cipher Pharmaceuticals Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cipher Pharmaceuticals Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Cipher Pharmaceuticals Inc. – Key Information
Cipher Pharmaceuticals Inc. – Overview
Cipher Pharmaceuticals Inc. – Key Employees
Cipher Pharmaceuticals Inc. – Key Employee Biographies
Cipher Pharmaceuticals Inc. – Key Operational Heads
Cipher Pharmaceuticals Inc. – Major Products and Services
Cipher Pharmaceuticals Inc. – History
Cipher Pharmaceuticals Inc. – Company Statement
Cipher Pharmaceuticals Inc. – Locations And Subsidiaries
Cipher Pharmaceuticals Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cipher Pharmaceuticals Inc. – Business Description
Cipher Pharmaceuticals Inc. – Corporate Strategy
Cipher Pharmaceuticals Inc. – SWOT Analysis
SWOT Analysis – Overview
Cipher Pharmaceuticals Inc. – Strengths
Cipher Pharmaceuticals Inc. – Weaknesses
Cipher Pharmaceuticals Inc. – Opportunities
Cipher Pharmaceuticals Inc. – Threats
Cipher Pharmaceuticals Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Cipher Pharmaceuticals Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cipher Pharmaceuticals Inc., Key Information
Cipher Pharmaceuticals Inc., Key Ratios
Cipher Pharmaceuticals Inc., Share Data
Cipher Pharmaceuticals Inc., Major Products and Services
Cipher Pharmaceuticals Inc., History
Cipher Pharmaceuticals Inc., Key Employees
Cipher Pharmaceuticals Inc., Key Employee Biographies
Cipher Pharmaceuticals Inc., Key Operational Heads
Cipher Pharmaceuticals Inc., Other Locations
Cipher Pharmaceuticals Inc., Subsidiaries
Cipher Pharmaceuticals Inc., Key Manufacturing facilities
Cipher Pharmaceuticals Inc., Key Competitors
Cipher Pharmaceuticals Inc., SWOT Analysis
Cipher Pharmaceuticals Inc., Ratios based on current share price
Cipher Pharmaceuticals Inc., Annual Ratios
Cipher Pharmaceuticals Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Cipher Pharmaceuticals Inc., Performance Chart
Cipher Pharmaceuticals Inc., Ratio Charts


★リサーチレポート[ Cipher Pharmaceuticals Inc. (CPH):企業の財務及び戦略的SWOT分析(Cipher Pharmaceuticals Inc. (CPH) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。